• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4658654)   Today's Articles (5469)   Subscriber (51274)
For: Weist BM, Hernandez JB, Walsh CM. Loss of DRAK2 signaling enhances allogeneic transplant survival by limiting effector and memory T cell responses. Am J Transplant 2012;12:2220-7. [PMID: 22494341 PMCID: PMC3396732 DOI: 10.1111/j.1600-6143.2012.04056.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Number Cited by Other Article(s)
1
Djurkovic F, Ferjancic Z, Bihelovic F. Intramolecular Dearomative Inverse-Electron-Demand Diels Alder Strategy for the Total Synthesis of (+)-Alstonlarsine A. J Org Chem 2023;88:11618-11626. [PMID: 37556165 DOI: 10.1021/acs.joc.3c00923] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/10/2023]
2
Zheng Y, Li X, Kuang L, Wang Y. New insights into the characteristics of DRAK2 and its role in apoptosis: From molecular mechanisms to clinically applied potential. Front Pharmacol 2022;13:1014508. [PMID: 36386181 PMCID: PMC9649744 DOI: 10.3389/fphar.2022.1014508] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Accepted: 10/12/2022] [Indexed: 11/27/2022]  Open
3
Ferjancic Z, Kukuruzar A, Bihelovic F. Total Synthesis of (+)‐Alstonlarsine A. Angew Chem Int Ed Engl 2022;61:e202210297. [DOI: 10.1002/anie.202210297] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Indexed: 12/31/2022]
4
Ferjancic Z, Kukuruzar A, Bihelovic F. Total Synthesis of (+)‐Alstonlarsine A. Angew Chem Int Ed Engl 2022. [DOI: 10.1002/ange.202210297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
5
Yang L, Huang Q, Fu J, Lin Z, Mao Q, Zhao L, Gao X, Chen S, Hua G, Li S. A novel and efficient method to induce allospecific CD8+ memory T lymphocytes. J Clin Lab Anal 2021;35:e23972. [PMID: 34465008 PMCID: PMC8529130 DOI: 10.1002/jcla.23972] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2021] [Revised: 07/12/2021] [Accepted: 08/09/2021] [Indexed: 12/26/2022]  Open
6
Investigation of indirubin derivatives: a combination of 3D-QSAR, molecular docking, and ADMET towards the design of new DRAK2 inhibitors. Struct Chem 2018. [DOI: 10.1007/s11224-018-1134-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
7
Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening. Bioorg Med Chem Lett 2016;26:2719-23. [PMID: 27106709 DOI: 10.1016/j.bmcl.2016.03.111] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2015] [Revised: 03/27/2016] [Accepted: 03/31/2016] [Indexed: 01/14/2023]
8
Cheng P, Zhong L, Jiang Z, Wang Y, Pan M, Gao YI. High-dose immunosuppressant alters the immunological status of New Zealand white rabbits following skin transplantation. Exp Ther Med 2015;10:1003-1008. [PMID: 26622429 DOI: 10.3892/etm.2015.2608] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2014] [Accepted: 05/01/2015] [Indexed: 11/06/2022]  Open
9
Edwards BA, Harris TL, Floersh H, Lukens JR, Zaki MH, Vogel P, Kanneganti TD, Bui JD, McGargill MA. Drak2 is not required for tumor surveillance and suppression. Int Immunol 2015;27:161-6. [PMID: 25568303 DOI: 10.1093/intimm/dxu146] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]  Open
10
Gao LJ, Kovackova S, Sála M, Ramadori AT, De Jonghe S, Herdewijn P. Discovery of dual death-associated protein related apoptosis inducing protein kinase 1 and 2 inhibitors by a scaffold hopping approach. J Med Chem 2014;57:7624-43. [PMID: 25178155 DOI: 10.1021/jm5007929] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
11
Leonczak P, Gao LJ, Ramadori AT, Lescrinier E, Rozenski J, De Jonghe S, Herdewijn P. Synthesis and structure-activity relationship studies of 2-(1,3,4-oxadiazole-2(3H)-thione)-3-amino-5-arylthieno[2,3-b]pyridines as inhibitors of DRAK2. ChemMedChem 2014;9:2587-601. [PMID: 25146684 DOI: 10.1002/cmdc.201402234] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2014] [Indexed: 12/28/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA